1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow talactoferrin alfa: new trials by email Literature Review of talactoferrin alfa trials Research Report on talactoferrin alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer talactoferrin, laboratory biomarker analysis - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Phase 1 | Terminated | Stanford University | 4 | 2012-05-01 | 2016-08-02 |
| Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants Talactoferrin, Placebo - Nosocomial Infections | Phase 1 / Phase 2 | Unknown | Agennix | 120 | 2009-06-01 | 2012-03-15 |
| Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer Talactoferrin, Apheresis - Non-Small Cell Lung Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 10 | 2008-06-19 | 2018-07-05 |
Carcinoma, Non-Small-Cell Lung (2) · Cross Infection (1) · Lung Neoplasms (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Tongue Neoplasms (1)
Agennix (1) · National Cancer Institute (NCI) (1) · Stanford University (1)
United States (3)
Heather Wakelee (1) · James L Gulley, M.D. (1)
R44HD057744 (1)